Isometric Companies, Inc., a privately held corporation today announced their new micro molding division, Isometric Micro Molding, Inc. With this new division, Isometric Companies, Inc. extends its global leadership in precision micro solutions which includes Isometric Tool & Design, Inc., a precision injection mold and automation fabrication company established in 1990. With 60 employees and 33,000 square feet of manufacturing space, Isometric becomes the largest medical-focused micro molder in the U.S serving the intraocular, vascular, neuromodulation, orthopedic, and drug delivery device markets.
Isometric Micro Molding, Inc. offers substantial value to their customers through the vertical integration of their in-house micro molding, micro mold fabrication, CT scanning metrology, and micro automation services. Isometric’s solutions-based micro molding capabilities enable worldwide, disruptive technologies and devices for Fortune 500 medical and drug delivery device OEMs. Combining talents from micro molding with micro mold making and micro automation divisions allows fluid, transparent, and cross-functional communication with customers, preventing the loss of valuable micro device technology transfer knowledge.
Devices such as transdermal patches, sheaths, anchors, capillaries, robotic surgery, and neurovascular implants are some of the examples of microscopic polymer components and sub-assemblies that Isometric Micro Molding, Inc. has helped customers bring to market. “One of the largest, publicly traded medical device companies in the world traveled the globe in search of a micro molding firm capable of singular micron tolerance molding and selected Isometric Micro Molding, Inc. because of our precision tooling and transparent customer service- both critical to medical device design history filing”, stated Isometric President Michael Hudalla.
We are committed to providing our customers with excellence in medical micro molding and assembly services and having these services under one company umbrella promotes a collaborative spirit with our customers and streamlines the development cycle tremendously”, quoted Donna Bibber, Vice President of Business Development. In doing so, customers are able to increase their speed to market and create shareholder value for critical care, life sustaining medical, implantable, and drug delivery devices.